162 related articles for article (PubMed ID: 32573292)
21. Comparative clinical prognosis of massive and non-massive pulmonary embolism: A registry-based cohort study.
Blondon M; Jimenez D; Robert-Ebadi H; Del Toro J; Lopez-Jimenez L; Falga C; Skride A; Font L; Vazquez FJ; Bounameaux H; Monreal M;
J Thromb Haemost; 2021 Feb; 19(2):408-416. PubMed ID: 33119949
[TBL] [Abstract][Full Text] [Related]
22. Venous thromboembolism in solid-organ transplant recipients: Findings from the RIETE registry.
García-Ortega A; López-Reyes R; Anguera G; Oscullo G; Rivas A; López-Jiménez L; Lorenzo A; Mahé I; Ciammaichella M; Monreal M;
Thromb Res; 2021 May; 201():131-138. PubMed ID: 33684796
[TBL] [Abstract][Full Text] [Related]
23. Editor's Choice - A Systematic Review and Meta-Analysis of the Efficacy and Safety of Anticoagulation in the Treatment of Venous Thromboembolism in Patients with Cancer.
Kirkilesis GI; Kakkos SK; Tsolakis IA
Eur J Vasc Endovasc Surg; 2019 May; 57(5):685-701. PubMed ID: 31097186
[TBL] [Abstract][Full Text] [Related]
24. Long-term follow-up of patients with venous thromboembolism and COVID-19: Analysis of risk factors for death and major bleeding.
Demelo-Rodríguez P; Ordieres-Ortega L; Ji Z; Del Toro-Cervera J; de Miguel-Díez J; Álvarez-Sala-Walther LA; Galeano-Valle F
Eur J Haematol; 2021 May; 106(5):716-723. PubMed ID: 33608914
[TBL] [Abstract][Full Text] [Related]
25. Risk of venous thromboembolism and bleeding after major surgery for ovarian cancer: standard in-hospital versus extended duration of thromboprophylaxis.
Wiegers HMG; Schaafsma M; Guman NAM; Zelisse HS; Mulder FI; Middeldorp S; van Es N; Mom CH
J Thromb Haemost; 2023 Feb; 21(2):294-302. PubMed ID: 36700503
[TBL] [Abstract][Full Text] [Related]
26. Omega-3 fatty acids predict recurrent venous thromboembolism or total mortality in elderly patients with acute venous thromboembolism.
Reiner MF; Stivala S; Limacher A; Bonetti NR; Méan M; Egloff M; Rodondi N; Aujesky D; von Schacky C; Lüscher TF; Camici GG; Beer JH
J Thromb Haemost; 2017 Jan; 15(1):47-56. PubMed ID: 27790827
[TBL] [Abstract][Full Text] [Related]
27. Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism.
Robertson L; Strachan J
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD006771. PubMed ID: 28195640
[TBL] [Abstract][Full Text] [Related]
28. Dynamics of case-fatalilty rates of recurrent thromboembolism and major bleeding in patients treated for venous thromboembolism.
Lecumberri R; Alfonso A; Jiménez D; Fernández Capitán C; Prandoni P; Wells PS; Vidal G; Barillari G; Monreal M;
Thromb Haemost; 2013 Oct; 110(4):834-43. PubMed ID: 23846721
[TBL] [Abstract][Full Text] [Related]
29. Incidence of VTE and Bleeding Among Hospitalized Patients With Coronavirus Disease 2019: A Systematic Review and Meta-analysis.
Jiménez D; García-Sanchez A; Rali P; Muriel A; Bikdeli B; Ruiz-Artacho P; Le Mao R; Rodríguez C; Hunt BJ; Monreal M
Chest; 2021 Mar; 159(3):1182-1196. PubMed ID: 33217420
[TBL] [Abstract][Full Text] [Related]
30. Risk factors of thrombotic recurrence and major bleeding in patients with intermediate-risk for recurrence of venous thromboembolism.
Yamashita Y; Amano H; Morimoto T; Kadota K; Hata R; Matsushita K; Osakada K; Sano A; Takase T; Hiramori S; Kim K; Oi M; Akao M; Kobayashi Y; Toyofuku M; Inoko M; Tada T; Chen PM; Murata K; Tsuyuki Y; Nishimoto Y; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Kato T; Ono K; Kimura T;
J Thromb Thrombolysis; 2022 Jan; 53(1):182-190. PubMed ID: 34228248
[TBL] [Abstract][Full Text] [Related]
31. The association of recurrence and bleeding events with mortality after venous thromboembolism: From the COMMAND VTE Registry.
Yamashita Y; Yoshikawa Y; Morimoto T; Amano H; Takase T; Hiramori S; Kim K; Oi M; Akao M; Kobayashi Y; Toyofuku M; Tada T; Chen PM; Murata K; Tsuyuki Y; Saga S; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Shiomi H; Kato T; Makiyama T; Ono K; Kimura T;
Int J Cardiol; 2019 Oct; 292():198-204. PubMed ID: 31239211
[TBL] [Abstract][Full Text] [Related]
32. [A single-center experience of venous thromboembolism after adult lung transplantation].
Zhao L; Wang C; Chen JY; Liang CY; Guo LJ; Li M; Chen WH
Zhonghua Jie He He Hu Xi Za Zhi; 2019 Sep; 42(9):694-699. PubMed ID: 31484244
[No Abstract] [Full Text] [Related]
33. Incidence, clinical characteristics and long-term prognosis of postoperative symptomatic venous thromboembolism: a retrospective cohort study.
Takeda C; Yamashita Y; Takeuchi M; Yonekura H; Dong L; Hamada M; Hirotsu A; Ono K; Kawakami K; Fukuda K; Morimoto T; Kimura T; Mizota T
BMJ Open; 2022 Feb; 12(2):e055090. PubMed ID: 35173005
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for recurrence and major bleeding in patients with cancer-associated venous thromboembolism.
Vedovati MC; Giustozzi M; Munoz A; Bertoletti L; Cohen AT; Klok FA; Connors JM; Bauersachs R; Brenner B; Campanini M; Becattini C; Agnelli G
Eur J Intern Med; 2023 Jun; 112():29-36. PubMed ID: 36774305
[TBL] [Abstract][Full Text] [Related]
35. Incidence and characteristics of venous thromboembolism in Asian patients with primary central nervous system lymphoma undergoing chemotherapy.
Byun JM; Hong J; Yoon SS; Koh Y; Ock CY; Kim TM; Lee JH; Kim SH; Lee JO; Bang SM; Yhim HY; Bae SH; Mun YC; Oh D;
Thromb Res; 2019 Nov; 183():131-135. PubMed ID: 31677593
[TBL] [Abstract][Full Text] [Related]
36. Direct oral anticoagulants in the treatment of venous thromboembolism, with a focus on patients with pulmonary embolism: an evidence-based review.
Gómez-Outes A; Suárez-Gea ML; Lecumberri R; Terleira-Fernández AI; Vargas-Castrillón E
Vasc Health Risk Manag; 2014; 10():627-39. PubMed ID: 25404858
[TBL] [Abstract][Full Text] [Related]
37. Predicting recurrences or major bleeding in women with cancer and venous thromboembolism. Findings from the RIETE Registry.
Trujillo-Santos J; Ruiz-Gamietea A; Luque JM; Samperiz AL; Garcia-Bragado F; Todoli JA; Monreal M;
Thromb Res; 2009; 123 Suppl 2():S10-5. PubMed ID: 19217463
[TBL] [Abstract][Full Text] [Related]
38. The occurrence of venous thromboembolism in cancer patients following major surgery.
Toledano TH; Kondal D; Kahn SR; Tagalakis V
Thromb Res; 2013 Jan; 131(1):e1-5. PubMed ID: 23174626
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.
Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH
Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628
[TBL] [Abstract][Full Text] [Related]
40. Systematic review and meta-analysis of outcomes in patients with suspected pulmonary embolism.
Patel P; Patel P; Bhatt M; Braun C; Begum H; Nieuwlaat R; Khatib R; Martins CC; Zhang Y; Etxeandia-Ikobaltzeta I; Varghese J; Alturkmani H; Bahaj W; Baig M; Kehar R; Mustafa A; Ponnapureddy R; Sethi A; Thomas M; Wooldridge D; Lim W; Bates SM; Lang E; Le Gal G; Haramati LB; Kline J; Righini M; Wiercioch W; Schünemann H; Mustafa RA
Blood Adv; 2021 Apr; 5(8):2237-2244. PubMed ID: 33900385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
